Brown Brothers Harriman & Co’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.7M Buy
494,308
+361,715
+273% +$29.2M 0.17% 98
2026
Q1
$11.5M Sell
132,593
-8,415
-6% -$806K 0.06% 139
2025
Q4
$13.5M Buy
141,008
+949
+0.7% +$92.2K 0.07% 119
2025
Q3
$13.3M Buy
140,059
+8,034
+6% +$739K 0.08% 110
2025
Q2
$11.5M Sell
132,025
-223
-0.2% -$18.9K 0.07% 112
2025
Q1
$11.9M Sell
132,248
-10,718
-7% -$959K 0.08% 111
2024
Q4
$11.4M Sell
142,966
-27,086
-16% -$2.34M 0.08% 107
2024
Q3
$15.3M Sell
170,052
-30,919
-15% -$2.6M 0.1% 101
2024
Q2
$15.8M Sell
200,971
-37,517
-16% -$3.08M 0.12% 93
2024
Q1
$20.8M Sell
238,488
-15,516
-6% -$1.32M 0.16% 73
2023
Q4
$20.9M Buy
254,004
+24,292
+11% +$1.85M 0.17% 62
2023
Q3
$18M Buy
229,712
+36,092
+19% +$3.02M 0.16% 64
2023
Q2
$17.1M Buy
193,620
+170,498
+737% +$14.7M 0.14% 66
2023
Q1
$1.86M Sell
23,122
-1,140
-5% -$92.9K 0.02% 183
2022
Q4
$1.89M Sell
24,262
-1,652
-6% -$134K 0.02% 158
2022
Q3
$2.09M Buy
25,914
+1,385
+6% +$124K 0.02% 152
2022
Q2
$2.2M Sell
24,529
-5,792
-19% -$587K 0.02% 153
2022
Q1
$3.36M Sell
30,321
-24,712
-45% -$2.61M 0.02% 141
2021
Q4
$5.69M Buy
55,033
+21,591
+65% +$2.5M 0.03% 113
2021
Q3
$4.19M Sell
33,442
-1,419
-4% -$184K 0.02% 119
2021
Q2
$4.33M Buy
34,861
+1,345
+4% +$169K 0.03% 119
2021
Q1
$3.96M Sell
33,516
-1,493
-4% -$175K 0.03% 121
2020
Q4
$4.1M Sell
35,009
-1,307
-4% -$144K 0.03% 121
2020
Q3
$3.77M Sell
36,316
-2,781
-7% -$279K 0.03% 118
2020
Q2
$3.58M Buy
39,097
+9,931
+34% +$952K 0.03% 116
2020
Q1
$2.63M Sell
29,166
-3,442
-11% -$366K 0.02% 127
2019
Q4
$3.7M Sell
32,608
-459
-1% -$50.4K 0.02% 128
2019
Q3
$3.59M Buy
33,067
+39
+0.1% +$4.07K 0.02% 125
2019
Q2
$3.22M Buy
33,028
+687
+2% +$62.7K 0.02% 127
2019
Q1
$2.95M Sell
32,341
-7,737
-19% -$692K 0.02% 130
2018
Q4
$3.65M Buy
40,078
+9,927
+33% +$928K 0.03% 120
2018
Q3
$2.97M Buy
30,151
+3,359
+13% +$311K 0.02% 127
2018
Q2
$2.29M Sell
26,792
-1,777
-6% -$148K 0.01% 133
2018
Q1
$2.29M Sell
28,569
-2,891
-9% -$238K 0.01% 131
2017
Q4
$2.54M Buy
31,460
+681
+2% +$54.5K 0.01% 130
2017
Q3
$2.39M Buy
30,779
+1,175
+4% +$97.6K 0.01% 126
2017
Q2
$2.63M Sell
29,604
-2,136
-7% -$180K 0.01% 118
2017
Q1
$2.56M Buy
31,740
+1,004
+3% +$78.4K 0.01% 121
2016
Q4
$2.19M Sell
30,736
-5,618
-15% -$441K 0.01% 131
2016
Q3
$3.14M Sell
36,354
-5,411
-13% -$472K 0.02% 111
2016
Q2
$3.62M Sell
41,765
-4,089
-9% -$331K 0.02% 106
2016
Q1
$3.44M Sell
45,854
-6,414
-12% -$483K 0.02% 110
2015
Q4
$4.02M Sell
52,268
-1,100
-2% -$82.8K 0.02% 105
2015
Q3
$3.57M Sell
53,368
-3,789
-7% -$279K 0.02% 112
2015
Q2
$4.24M Sell
57,157
-2,657
-4% -$203K 0.02% 106
2015
Q1
$4.67M Buy
59,814
+1,349
+2% +$102K 0.02% 102
2014
Q4
$4.22M Sell
58,465
-1,322
-2% -$91.8K 0.02% 112
2014
Q3
$3.7M Sell
59,787
-14,963
-20% -$951K 0.01% 118
2014
Q2
$4.77M Sell
74,750
-5,320
-7% -$323K 0.02% 114
2014
Q1
$4.93M Sell
80,070
-77,094
-49% -$4.49M 0.02% 106
2013
Q4
$9.02M Buy
157,164
+78,206
+99% +$4.43M 0.02% 109
2013
Q3
$4.21M Sell
78,958
-4,075
-5% -$219K 0.02% 107
2013
Q2
$4.27M Buy
+83,033
New +$4.1M 0.02% 119

Other funds holding MDT

Brown Brothers Harriman & Co's MDT Position: Q2 2026 in Review

Brown Brothers Harriman & Co increased its Medtronic (MDT) stake by 273% in Q2 2026, buying an estimated $29.2M and bringing the position to 494,308 shares worth $38.7M. The position accounts for 0.17% of the portfolio, ranked #98.

Brown Brothers Harriman & Co first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Brown Brothers Harriman & Co held 494,308 shares of Medtronic worth $38.7M as of Q2 2026.
  • Brown Brothers Harriman & Co bought 361,715 Medtronic shares in Q2 2026, an estimated $29.2M.
  • Medtronic made up 0.17% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #98 holding.
  • Brown Brothers Harriman & Co first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.